Benzinga's Top Pre-Market Losers

by Lisa Levin, Benzinga Editor
July 2, 2013 8:20 AM | 1 min read | Make a Comment
Loading...
Loading...
Achillion Pharmaceuticals
ACHN
dipped 24.04% to $6.35 in the pre-market session after an FDA study on the company's drug Sovarprevir was placed on hold. Linn Energy LLC
LINE
shares fell 9.49% to $30.13 in the pre-market trading on JP Morgan downgrade and announcement of informal SEC inquiry. Silicon Motion Technology
SIMO
shares dropped 9.35% to $9.70 in pre-market trading after the company announced preliminary Q2 revenue. DaVita HealthCare Partners
DVA
dipped 8.74% to $110.56 in the pre-market session. Raymond James downgraded DaVita from “outperform” to “market perform.”
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Posted In: NewsMovers & ShakersPre-Market OutlookMarketsEnergyOil & Gas Exploration & ProductionTop Pre-Market Losers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!